Log in with your email address username.


[Correspondence] Curbing the circulation of counterfeit medicines in Nigeria

At the recently concluded 66th session of the WHO Regional Committee for Africa, held in Addis Ababa, Aug 19–23, 2016, Nigerian policy makers again affirmed their commitment to the fight against the circulation of counterfeit medicines in the country, and urged other member states to do the same.1 Although Nigeria (Africa’s most populous nation) has reported progress in reducing its circulating counterfeit medicines, from 40% in 2001 to 16·7% in 2005,1 this problem remains a considerable challenge, particularly with regard to medicines of public health importance, such as antimalarial drugs.